Literature DB >> 10992370

Bacterial dna sequences in prostate tissue from patients with prostate cancer and chronic prostatitis.

J N Krieger1, D E Riley, R L Vesella, D C Miner, S O Ross, P H Lange.   

Abstract

PURPOSE: Although bacterial genetic material has been detected in prostate tissue from patients with various disorders, the prevalence of these organisms is unknown. We tested the hypothesis that bacterial detection rates differ between patients with prostate cancer and those with the chronic prostatitis/pelvic pain syndrome.
MATERIALS AND METHODS: Sterile prostate biopsies were obtained during radical retropubic prostatectomy from 107 patients with prostate cancer and using a perineal approach from 170 with the chronic prostatitis/pelvic pain syndrome. Numerous controls were also evaluated. Bacterial ribosomal encoding DNA (165 rDNA) sequences were detected using a polymerase chain reaction assay. Selected positives were cloned, sequenced and compared with DNA databases.
RESULTS: Bacterial DNA sequences were detected in 21 (19. 6%) of 107 patients with prostate cancer compared to 79 (46.4%) of 170 with chronic prostatitis (p <0.0001). These bacteria included urogenital pathogens, other described microorganisms and bacteria not reported previously.
CONCLUSIONS: Bacterial DNA sequences may be identified in prostate tissue from many patients. Bacterial detection rates in prostate tissue appear to differ among populations, with higher rates among patients with the chronic prostatitis/pelvic pain syndrome than among those with prostate cancer. Future studies of the role of various bacteria in the prostate may provide insight into the pathophysiology of prostate disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992370

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

Review 1.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 2.  Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Hans C Arora; Charis Eng; Daniel A Shoskes
Journal:  Ann Transl Med       Date:  2017-01

3.  Effect of hypertension on bacteria composition of prostate biopsy in patients with benign prostatic hyperplasia and prostate cancer in PSA grey-zone.

Authors:  Xiaofeng Ni; Hongzhou Meng; Feng Zhou; Haining Yu; Jianjian Xiang; Shengrong Shen
Journal:  Biomed Rep       Date:  2016-04-14

4.  A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.

Authors:  Brian W Simons; Nicholas M Durham; Tullia C Bruno; Joseph F Grosso; Anthony J Schaeffer; Ashley E Ross; Paula J Hurley; David M Berman; Charles G Drake; Praveen Thumbikat; Edward M Schaeffer
Journal:  J Pathol       Date:  2015-02       Impact factor: 7.996

5.  Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model.

Authors:  K E Rippere-Lampe; M Lang; H Ceri; M Olson; H A Lockman; A D O'Brien
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 6.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  Molecular markers in prostate cancer. Part I: predicting lethality.

Authors:  Sachin Agrawal; William D Dunsmuir
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

8.  Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells.

Authors:  Johanna B Drott; Oleg Alexeyev; Patrik Bergström; Fredrik Elgh; Jan Olsson
Journal:  BMC Microbiol       Date:  2010-04-26       Impact factor: 3.605

Review 9.  Chronic pelvic pain syndrome and voiding dysfunction.

Authors:  Werner W Hochreiter; Sebastian Z'Brun
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

10.  Antibiotic and anti-inflammatory use and the risk of prostate cancer.

Authors:  Nicholas A Daniels; Yea-Hung Chen; Stephen Bent
Journal:  BMC Res Notes       Date:  2009-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.